metabolic syndrome. Metabolic syndrome
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Adults 20-55 years old Metabolic syndrome based on modified ATPIII criteria
Exclusion criteria
Exclusion criteria: Having cardiovascular, liver, kidney, thyroid and diabetes diseases Pregnancy and lactation Follow a special diet Use of drugs that affect appetite, blood pressure, inflammation, fat metabolism and carbohydrates Use of multivitamin-mineral supplements, fatty acids and herbal remedies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance (Fasting blood sugar, Insulin, HOMA- IR?QUICKI). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits.;Antioxidant status (MDA,CTL,SOD). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: En Existing commercial kits.;Inflammation status (CRP). Timepoint: At the beginning and end of each Six-week intervention. Method of measurement: Existing commercial kits. | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist Circumference. Timepoint: At the beginning and end of each intervention period. Method of measurement: Meters irreversible.;Weight. Timepoint: At the beginning and end of each intervention period. Method of measurement: Digital Balance.;BMI. Timepoint: At the beginning and end of each intervention period. Method of measurement: Divide the weight by the square of the height. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences